Behavioral effects of the benzodiazepine-positive allosteric modulator SH-053-2'F-S-CH3 in an immune-mediated neurodevelopmental disruption model

International Journal of Neuropsychopharmacology

Volumn 18, Issue 4, 2014, Pages 1-11

  Richetto, Juliet ^a   Labouesse, Marie A ^b   Poe, Michael M ^c   Cook, James M ^c   Grace, Anthony A ^d   Riva, Marco A ^a   Meyer, Urs ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b ETH ZURICH   (Switzerland)

^c UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Autism; GABA; Infection; Poly(I:C); Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA2; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA3; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA5; AMPHETAMINE; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; DEXAMPHETAMINE; POLYINOSINIC POLYCYTIDYLIC ACID; SH 053 2'F S CH 3; UNCLASSIFIED DRUG; BENZODIAZEPINE DERIVATIVE; CENTRAL STIMULANT AGENT; GABAERGIC RECEPTOR AFFECTING AGENT; POLY(RI).POLY(DC); POLYNUCLEOTIDE; PSYCHOTROPIC AGENT;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR CINGULATE; ARTICLE; AUTISM; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; DEVELOPMENTAL DISORDER; DOPAMINERGIC SYSTEM; DORSAL HIPPOCAMPUS; DRUG SELECTIVITY; DRUG SENSITIVITY; FEMALE; HYPERACTIVITY; IMMUNOREACTIVITY; LOCOMOTION; MALE; MEDIAL PREFRONTAL CORTEX; NERVE CELL DIFFERENTIATION; NEUROPHARMACOLOGY; NONHUMAN; OPEN FIELD TEST; PHENOTYPE; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR AFFINITY; SCHIZOPHRENIA; SOCIAL INTERACTION; SOCIAL INTERACTION TEST; SOCIAL RECOGNITION TEST; SPATIAL MEMORY; VENTRAL HIPPOCAMPUS; WORKING MEMORY; Y-MAZE TEST; ANIMAL; C57BL MOUSE; COGNITION DISORDERS; DISEASE MODEL; DRUG EFFECTS; HIPPOCAMPUS; METABOLISM; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREFRONTAL CORTEX; PREGNANCY; PRENATAL EXPOSURE; SHORT TERM MEMORY; SOCIAL BEHAVIOR;

AMPHETAMINE; ANIMALS; BENZODIAZEPINES; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; FEMALE; GABA AGENTS; HIPPOCAMPUS; MALE; MEMORY, SHORT-TERM; MICE, INBRED C57BL; MOTOR ACTIVITY; POLYNUCLEOTIDES; PREFRONTAL CORTEX; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PSYCHOTROPIC DRUGS; RECEPTORS, GABA-A; SOCIAL BEHAVIOR;

EID: 84939160954     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyu055     Document Type: Article

References (62)

1. Benes FM, Berretta S (2001) GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25:1-27.
2. Beneyto M, Abbott A, Hashimoto T, Lewis DA (2011) Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. Cereb Cortex 21:999-1011.
3. Bitanihirwe BK, Peleg-Raibstein D, Mouttet F, Feldon J, Meyer U (2010) Late prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophrenia. Neuropsychopharmacology 35:2462-2478.
4. Bitanihirwe BK, Weber L, Feldon J, Meyer U (2010) Cognitive impairment following prenatal immune challenge in mice correlates with prefrontal cortical AKT1 deficiency. Int J Neuropsychop 13:981-996.
5. Blatt GJ, Fatemi SH (2011) Alterations in GABAergic biomarkers in the autism brain: research findings and clinical implications. Anat Rec 294:1646-1652.
6. Brown AS, Derkits EJ (2010) Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psych 167:261-280.
7. Buchanan RW, Keefe RS, Lieberman JA, Barch DM, Csernansky JG, Goff DC, Gold JM, Green MF, Jarskog LF, Javitt DC, Kimhy D, Kraus MS, McEvoy JP, Mesholam-Gately RI, Seidman LJ, Ball MP, McMahon RP, Kern RS, Robinson J, Marder SR (2011) A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. Biol Psychiatry 69:442-449.
8. Castner SA, Arriza JL, Roberts JC, Mrzljak L, Christian EP, Williams GV (2010) Reversal of ketamine-induced working memory impairments by the GABAAalpha2/3 agonist TPA023. Biol Psychiatry 67:998-1001.
9. Collinson N, Kuenzi FM, Jarolimek W, Maubach KA, Cothliff R, Sur C, Smith A, Otu FM, Howell O, Atack JR, McKernan RM, Seabrook GR, Dawson GR, Whiting PJ, Rosahl TW (2002) Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor. J Neurosci 22:5572-5580.
10. Connor CM, Dincer A, Straubhaar J, Galler JR, Houston IB, Akbarian S (2012) Maternal immune activation alters behavior in adult offspring, with subtle changes in the cortical transcriptome and epigenome. Schizophr Res 140:175-184.
11. Cook JM, Zhou H, Huang S, Sarma PV et al (2009) Stereospecific and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects. United States of America. US Patent 7, 618, 458.
12. Crestani F, Keist R, Fritschy JM, Benke D, Vogt K, Prut L, Bluthmann H, Mohler H, Rudolph U (2002) Trace Fear conditioning involves hippocampal alpha5 GABA(A) receptors (2002) Proc Natl Acad Sci USA 99:8980-8985.
13. Dawson GR, Maubach KA, Collinson N, Cobain M, Everitt BJ, MacLeod AM, Choudhury HI, McDonald LM, Pillai G, Rycroft W, Smith AJ, Sternfeld F, Tattersall FD, Wafford KA, Reynolds DS, Seabrook GR, Atack JR (2006) An inverse agonist selective for alpha5 subunit-containing GABAA receptors enhances cognition. J Pharm Exp Ther 316:1335-1345.
14. Dellu F, Mayo W, Cherkaoui J, Le Moal M, Simon H (1992) A twotrial memory task with automated recording: study in young and aged rats. Brain Res 588:132-139.
15. Duncan CE, Webster MJ, Rothmond DA, Bahn S, Elashoff M, Shannon Weickert C (2010) Prefrontal GABA(A) receptor alphasubunit expression in normal postnatal human development and schizophrenia. J Psychiatr Res 44:673-681.
16. Fischer BD, Licata SC, Edwankar RV, Wang ZJ, Huang S, He X, Yu J, Zhou H, Johnson EM Jr, Cook JM, Furtmüller R, Ramerstorfer J, Sieghart W, Roth BL, Majumder S, Rowlett JK (2010) Anxiolytic- like effects of 8-acetylene imidazobenzodiazepines in a rhesus monkey conflict procedure. Neuropharmacology 59:612-618.
17. Foussias G, Remington G (2010) Negative symptoms in schizophrenia: avolition and Occam's razor. Schizophr Bull 36:359-369.
18. Fung SJ, Webster MJ, Sivagnanasundaram S, Duncan C, Elashoff M, Weickert CS (2010) Expression of interneuron markers in the dorsolateral prefrontal cortex of the developing human and in schizophrenia. Am J Psych 167(12):1479-88.
19. Gerdjikov TV, Rudolph U, Keist R, Möhler H, Feldon J, Yee BK (2008) Hippocampal alpha 5 subunit-containing GABA A receptors are involved in the development of the latent inhibition effect. Neurobiol Learn Mem 89:87-94.
20. Gill KM, Lodge DJ, Cook JM, Aras S, Grace AA (2011) A novel α5GABA(A)R-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia. Neuropsychopharmacology 36:1903-1911.
21. Giovanoli S, Weber L, Meyer U (2014) Single and combined effects of prenatal immune activation and peripubertal stress on parvalbumin and reelin expression in the hippocampal formation. Brain Behav Immun, in press (doi: 10.1016/j.bbi.2014.04.005).
22. Gonzalez-Burgos G, Fish KN, Lewis DA (2011) GABA neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia. Neural Plast 2011:723184.
23. Gonzalez-Burgos G, Lewis DA (2012) NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia. Schizophr Bull 38:950-957.
24. Grace AA (2010) Dopamine system dysregulation by the ventral subiculum as the common pathophysiological basis for schizophrenia psychosis, psychostimulant abuse, and stress. Neurotox Res 18:367-376.
25. Grace AA (2012) Dopamine system dysregulation by the hippocampus: implications for the pathophysiology and treatment of schizophrenia. Neuropharmacology 62:1342-1348.
26. Guidotti A, Auta J, Davis JM, Dong E, Grayson DR, Veldic M, Zhang X, Costa E (2005) GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon. Psychopharmacology 180:191-205.
27. Guidotti G, Calabrese F, Auletta F, Olivier J, Racagni G, Homberg J, Riva MA (2012) Developmental influence of the serotonin transporter on the expression of npas4 and GABAergic markers: modulation by antidepressant treatment. Neuropsychopharmacology 37:746-758.
28. Hashimoto T, Arion D, Unger T, Maldonado-Avilés JG, Morris HM, Volk DW, Mirnics K, Lewis DA (2008) Alterations in GABArelated transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry 13:147-161.
29. Hashimoto T, Bazmi HH, Mirnics K, Wu Q, Sampson AR, Lewis DA (2008) Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. Am J Psych 165:479-489.
30. Hauser J, Rudolph U, Keist R, Möhler H, Feldon J, Yee BK (2005) Hippocampal alpha5 subunit-containing GABAA receptors modulate the expression of prepulse inhibition. Mol Psychiatry 10:201-207.
31. Konradi C, Yang CK, Zimmerman EI, Lohmann KM, Gresch P, Pantazopoulos H, Berretta S, Heckers S (2011) Hippocampal interneurons are abnormal in schizophrenia. Schizophr Res 131:165-173.
32. Laruelle M (2000) The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies. Brain Res Brain Res Rev 31:371-384.
33. Laruelle M, Abi-Dargham A (1999) Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies. J Psychopharmacol 13:358-371.
34. Lewis DA, Cho RY, Carter CS, Eklund K, Forster S, Kelly MA, Montrose D (2008) Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia. Am J Psych 165:1585-1593.
35. Lewis DA, Curley AA, Glausier JR, Volk DW (2012) Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci 35:57-67.
36. Lewis DA, Moghaddam B (2006) Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Arch Neurol 63:1372-1376.
37. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
38. Lodge DJ, Grace AA (2011) Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia. Trends Pharmacol Sci 32:507-513.
39. Meyer U (2014) Prenatal poly(I:C) exposure and other developmental immune activation models in rodent systems. Biol Psychiatry 75:307-315.
40. Meyer U, Feldon J (2010) Epidemiology-driven neurodevelopmental animal models of schizophrenia. Prog Neurobiol 90:285-326.
41. Meyer U, Feldon J, Schedlowski M, Yee BK (2005) Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev 29:913-947.
42. Meyer U, Nyffeler M, Yee BK, Knuesel I, Feldon J (2008) Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice. Brain Behav Immun 22:469-486.
43. Meyer U, Knuesel I, Nyffeler M, Feldon J (2010) Chronic clozapine treatment improves prenatal infection-induced working memory deficits without influencing adult hippocampal neurogenesis. Psychopharmacology 208:531-543.
44. Milić M, Timić T, Joksimović S, Biawat P, Rallapalli S, Divljaković J, Radulović T, Cook JM, Savić MM (2013) PWZ-029, an inverse agonist selective for α GABAA receptors, improves object recognition, but not water-maze memory in normal and scopolamine- treated rats. Behav Brain Res 241:206-213.
45. Morris HM, Hashimoto T, Lewis DA (2008) Alterations in mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder. Cereb Cortex 18:1575-1587.
46. Nyffeler M, Meyer U, Yee BK, Feldon J, Knuesel I (2006) Maternal immune activation during pregnancy increases limbic GABAA receptor immunoreactivity in the adult offspring: implications for schizophrenia. Neuroscience 143:51-62.
47. Ozawa K, Hashimoto K, Kishimoto T, Shimizu E, Ishikura H, Iyo M (2006) Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol Psychiatry 59:546-554.
48. Piontkewitz Y, Assaf Y, Weiner I (2009) Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia. Biol Psychiatry 66:1038-1046.
49. Piontkewitz Y, Arad M, Weiner I (2011) Abnormal trajectories of neurodevelopment and behavior following in utero insult in the rat. Biol Psychiatry 70:842-851.
50. Piontkewitz Y, Bernstein HG, Dobrowolny H, Bogerts B, Weiner I, Keilhoff G (2012) Effects of risperidone treatment in adolescence on hippocampal neurogenesis, parvalbumin expression, and vascularization following prenatal immune activation in rats. Brain Behav Immun 26:353-363.
51. Redrobe JP, Elster L, Frederiksen K, Bundgaard C, de Jong IE, Smith GP, Bruun AT, Larsen PH, Didriksen M (2012) Negative modulation of GABAA α5 receptors by RO4938581 attenuates discrete sub-chronic and early postnatal phencyclidine (PCP)-induced cognitive deficits in rats. Psychopharmacology 221:451-468.
52. Richetto J, Calabrese F, Meyer U, Riva MA (2013) Prenatal versus postnatal maternal factors in the development of infectioninduced working memory impairments in mice. Brain Behav Immun 33:190-200.
53. Richetto J, Calabrese F, Riva MA, Meyer U (2014) Prenatal immune activation induces maturation-dependent alterations in the prefrontal GABAergic transcriptome. Schizophr Bull 40:351-361.
54. Savić MM, Majumder S, Huang S, Edwankar RV, Furtmüller R, Joksimović S, Clayton T Sr, Ramerstorfer J, Milinković MM, Roth BL, Sieghart W, Cook JM (2010) Novel positive allosteric modulators of GABAA receptors: do subtle differences in activity at alpha1 plus alpha5 versus alpha2 plus alpha3 subunits account for dissimilarities in behavioral effects in rats? Prog Neuropsychopharmacol Biol Psychiatry 34:376-386.
55. Stan AD, Lewis DA (2012) Altered cortical GABA neurotransmission in schizophrenia: insights into novel therapeutic strategies. Curr Pharm Biotechnol 13:1557-1562.
56. Steullet P, Cabungcal JH, Kulak A, Kraftsik R, Chen Y, Dalton TP, Cuenod M, Do KQ (2010) Redox dysregulation affects the ventral but not dorsal hippocampus: impairment of parvalbumin neurons, gamma oscillations, and related behaviors. J Neurosci 30:2547-2558.
57. Tan S, Rudd JA, Yew DT (2011) Gene expression changes in GABA(A) receptors and cognition following chronic ketamine administration in mice. PLOS ONE 6:e21328.
58. Volk DW, Lewis DA (2013) Prenatal ontogeny as a susceptibility period for cortical GABA neuron disturbances in schizophrenia. Neuroscience 248C:154-164.
59. Volk DW, Pierri JN, Fritschy JM, Auh S, Sampson AR, Lewis DA (2002) Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. Cereb Cortex 12:1063-1070.
60. Zierhut K, Bogerts B, Schott B, Fenker D, Walter M, Albrecht D, Steiner J, Schütze H, Northoff G, Düzel E, Schiltz K (2010) The role of hippocampus dysfunction in deficient memory encoding and positive symptoms in schizophrenia. Psychiatry Res 183:187-194.
61. Zorrilla EP (1997) Multiparous species present problems (and possibilities) to developmentalists. Dev Psychobiol 30:141-150.
62. Zuckerman L, Rehavi M, Nachman R, Weiner I (2003) Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology 28:1778-1789.